Home » Newsletters » BioWorld Science

BioWorld Science

June 8, 2004

View Archived Issues

Enrollment completed in phase IIb trial of AOD-9604 for obesity

Approvable letter for RSR-13

Urotensin-II receptor antagonist effective against renal ischemia in vivo

Novel PARP inhibitor attenuates neuronal damage in in vivo models of cerebral ischemia

Novel compound by Chugai boosts chondrogenesis in vitro and in vivo

Synthetic N-acylated glucosamines promising for treatment of arthritis

Anti-IL-13 antibody with potential for the treatment of asthma

Encysive to retain Thelin marketing rights

Not approvable letter for proposed Angiomax label amendment

XL-647 advances into phase I

GenoMed expands trials into viruses that cause hemorrhagic fever

Abbott to reacquire rights to trandolapril from Aventis

Probuphine completes pilot study for opiate addiction

European MAA submission for Antegren for MS

Transform collaborates with Abbott to enhance drug development programs

Cerylid Biosciences completes transaction to acquire Kinacia

Toyama Chemical commences clinical study with T-817

Amgen Q1 highlighted by approval of Sensipar

Guilford updates Q1 progress

R&D programs at Galen continue to advance during first half of 2004

Vitamin C disappoints in diabetes study

KF-19514 ameliorates asthma parameters in vivo

Rhinovirus infection blocked by lansoprazole

Brigham and Women's Hospital and Prous Science sign agreement to launch Global Grand Rounds

BCX-2798 and BCX-2855 show efficacy against human parainfluenza viruses

The antidiabetic agent BLX-1002 subject of various presentations at ADA

Retinoid X receptor antagonist improves glucose and lipid metabolism in vivo

Agonistic antibodies to Epo receptors and their use as antianemic agents

Anti-GDF-8 antibodies and their use patented by Wyeth and Cambridge Antibody Technology

Anti-IFN-gamma antibodies developed by scientists at Amgen and Medarex

Abbott claims three series of compounds for epilepsy, migraine and bipolar disorder

Amersham patent covers targeted Tc complexes as MRI agents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...